About
Acceptance rate:
34%
Time to first decision without review:
24 days*
Acceptance to publication:
19 days*
Citescore:
1.8
Total content views:
89,243
Aims and scope
BMJ Innovations is a peer reviewed online journal focused on emerging digital technologies, novel medical devices, process and system innovations. The journal champions high-quality original research, early-stage innovation reports, and systemic and narrative reviews.
Along with a rich mix of news, discussion and debate it aims to ensure innovators, clinicians, leaders and policy makers stay informed on and accelerate the adoption of the latest innovations that will make the biggest impact on health.
The journal focuses on three broad areas of innovation:
- Digital health
- Medical devices
- Process and system innovation
Plan S compliance
BMJ Innovations is a Plan S compliant Transformative Journal. Transformative Journals are one of the compliance routes offered by cOAlition S funders, such as Wellcome, WHO and UKRI. Find out more about Transformative Journals and Plan S compliance on our Author Hub.
Journal information
Ownership
BMJ Innovations is owned by BMJ
Publication Model
Subscription; with hybrid open access option
Frequency
Quarterly
Launch date
2014
Indexed by
Web of Science Core Collection: Emerging Sources Citation Index, Scopus, Embase (Excerpta Medica), Google Scholar
Not currently indexed for MEDLINE. BMJ Innovations will deposit NIH funded manuscripts to PubMed Central as part of the NIH Public Access Policy.
Peer Review Model
Single anonymised; the names of reviewers are hidden from the author
Print ISSN
2055-8074
Online ISSN
2055-642X
Journal Statistics 2022
Acceptance rate: 34%
Speed
Time to first decision without review (median): 24 days
Time to first decision with review (median): 91 days
Time from acceptance to publication (median): 19 days
Impact
Citescore: 1.8
Citescore rank: 355/826
SciMago Journal Rank (SJR): 0.327
Reach
2022 total content views: 89,243
2022 total Altmetric mentions: 696
The impact that academic research has cannot be defined by one single metric. In 2013, BMJ signed the San Francisco Declaration on Research Assessment (DORA). We did this to show our support for using multiple measures and metrics to portray journals’ impact; moving away from the Impact Factor as a single measure.
How we get these metrics
Contact information
For all contact information please refer to the contact us page.
For authors
Please refer to the Instructions for authors
Rights and Permissions
Affiliations
The World Innovation Summit for Health (WISH) is a global healthcare community dedicated to capturing and disseminating the best evidence-based ideas and practices; sharing BMJ’s vision for a healthier world. BMJ Innovations and WISH have a strategic partnership.
BMJ is a founding member of COPE (the Committee on Publication Ethics), which provides a forum for publishers and Editors of scientific journals to discuss issues about the integrity of the work submitted to or published in their journals.
The EQUATOR Network is an international initiative that seeks to improve the value of medical research literature by promoting accurate, transparent reporting of research studies. BMJ is a sponsor of its activities.
BMJ is a founding organisation of the AllTrials initiative, which calls for all past and present clinical trials to be registered and their results reported.